Memon, Muhammad A.
Karaca, Burcak
Aboelhassan, Rasha
Barsoum, Mohsen
Erman, Mustafa
Basaran, Mert
Sevinc, Alper
Hanene, Djedi
Slader, Cassandra
Pilipovic, Virginia
Esma, Kerboua
Kamel, Bouzid
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 7 June 2018
Accepted: 17 July 2018
First Online: 13 August 2018
Compliance with ethical standards
:
: BK reports being speaker or taking part in advisory board of BMS, Novartis, Boehringer Ingelheim and Roche. ME reports being speaker or taking part in advisory board of Novartis, Roche, Pfizer, AstraZeneca, Takeda, Boehringer Ingelheim, Janssen, Sanofi, MSD, BMS, Astellas, and received honoraria from Astellas, Janssen, Boehringer, Roche, Pfizer, Novartis, Sanofi, Nobel and MSD. MB reports being speaker or taking part in advisory board of Bristol Myers and Pfizer, and received honoraria from Pfizer. DH reports advisory board, speaker or grants research support from Novartis, Sanofi, Roche, Bayer, Lilly, Amgen, AstraZeneca, Clinica Group, Abdi Ibrahim Remed Pharma, Janssen, Ipsen, Leo pharma, Boehringer, Pfizer, Merck, MSD, Becker, Vygon, Pierre Fabre, and El Kendi. KE reports being speaker or taking part in advisory board of MSD, El Kendi and Pfizer. BK reports being speaker or taking part in advisory board of Sanofi, MSD, Roche, Lilly and Pfizer. CS and VP are full-time employees of Novartis Pharmaceuticals Corporation and hold stocks of the company. RA, MB, and AS have nothing to disclose.